CLINICAL_TRIALS
trial_result
· 2025-09-18
Clinical Trial Update: Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease [Phase 2]
Summary
Phase 2 trial update assessing the efficacy and safety of obefazimod in adults with moderately to severely active Crohn's disease; the study is currently recrui…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abivax S.A. | Conditions: Moderately to Severely Active Crohn Disease | Phase 2 | Status: RECRUITING